A Comparison of Treponema pallidum Subspecies pallidum Molecular Typing Systems: Multilocus Sequence Typing vs. Enhanced Centers for Disease Control and Prevention Typing

Two Treponema pallidum subspecies pallidum strain typing systems differed in discriminatory ability. Individual strain types in both systems were more common in individuals with neurosyphilis. Supplemental digital content is available in the text. Background At least 3 syphilis typing systems are proposed. Recent work suggests that multilocus sequence typing (MLST) may be superior to enhanced Centers for Disease Control and Prevention typing (ECDCT) by yielding a higher discriminatory power. The goal of this study was to compare the 2 systems and identify associations between neurosyphilis and strain types. Methods Multilocus sequence typing for tp0136, tp0548, and tp0705 was determined for DNA from 78 Treponema pallidum subspecies pallidum isolates propagated in rabbits, 10 oral and 10 genital or non-genital lesion swabs, and 10 blood samples from patients with syphilis. These samples were chosen because they were completely typeable by ECDCT. Using both systems, association between strain types and neurosyphilis, defined as a reactive cerebrospinal fluid Venereal Disease Research Laboratory test, was determined. Partial and complete ECDCT types were also determined for samples from different anatomical sites in 35 patients, and from blood and blood isolates (rabbit propagated) from 13 patients. Results The MLST type could be fully determined for 100 (92.6%) of 108 samples. Although MLST subdivided 3 common ECDCT types, it failed to distinguish among others. Neurosyphilis was more common in individuals infected with type 1.1.2 and tp0705 type 2 using MLST, and tp0548 type f using ECDCT. Enhanced Centers for Disease Control and Prevention typing was stable among anatomical sites and between patient-derived and rabbit propagated organisms. Conclusions Compared with ECDCT, MLST was not uniformly more discriminating. Both typing systems demonstrate that specific types may be more neurotropic than others.

[1]  D. Šmajs,et al.  MLST typing of Treponema pallidum subsp. pallidum in the Czech Republic during 2004-2017: Clinical isolates belonged to 25 allelic profiles and harbored 8 novel allelic variants , 2019, PloS one.

[2]  K. Jolley,et al.  A public database for the new MLST scheme for Treponema pallidum subsp. pallidum: surveillance and epidemiology of the causative agent of syphilis , 2019, PeerJ.

[3]  O. Blanco,et al.  Multilocus Sequence Typing of Treponema pallidum subsp. pallidum in Cuba From 2012 to 2017 , 2018, The Journal of infectious diseases.

[4]  A. Gayet-Ageron,et al.  Molecular characterization of Treponema pallidum subsp. pallidum in Switzerland and France with a new multilocus sequence typing scheme , 2018, PloS one.

[5]  N. Dupin,et al.  Multi-locus sequence typing of Treponema pallidum subsp. pallidum present in clinical samples from France: Infecting treponemes are genetically diverse and belong to 18 allelic profiles , 2018, PloS one.

[6]  S. Norris,et al.  Long-Term In Vitro Culture of the Syphilis Spirochete Treponema pallidum subsp. pallidum , 2018, mBio.

[7]  G. Ciccarese,et al.  Enhanced Molecular Typing of Treponema pallidum subspecies pallidum Strains From 4 Italian Hospitals Shows Geographical Differences in Strain Type Heterogeneity, Widespread Resistance to Macrolides, and Lack of Mutations Associated With Doxycycline Resistance , 2017, Sexually transmitted diseases.

[8]  L. Bachmann,et al.  Syphilis ascendant: a brief history and modern trends , 2016, Tropical Diseases, Travel Medicine and Vaccines.

[9]  Robyn Neblett Fanfair,et al.  Molecular Typing of Treponema pallidum in Ocular Syphilis , 2016, Sexually transmitted diseases.

[10]  D. Vorobyev,et al.  Syphilis epidemiology in 1994–2013, molecular epidemiological strain typing and determination of macrolide resistance in Treponema pallidum in 2013–2014 in Tuva Republic, Russia , 2016, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[11]  J. Jensen,et al.  Molecular Typing of Treponema pallidum in Denmark: A Nationwide Study of Syphilis. , 2016, Acta dermato-venereologica.

[12]  N. Dupin,et al.  Molecular subtyping of Treponema pallidum in Paris, France. , 2013, Sexually transmitted diseases.

[13]  D. Šmajs,et al.  Comparison of CDC and sequence-based molecular typing of syphilis treponemes: tpr and arp loci are variable in multiple samples from the same patient , 2013, BMC Microbiology.

[14]  C. Marra,et al.  Two Mutations Associated With Macrolide Resistance in Treponema pallidum: Increasing Prevalence and Correlation With Molecular Strain Type in Seattle, Washington , 2012, Sexually transmitted diseases.

[15]  P. Zhou,et al.  Molecular Typing of Treponema pallidum: a 5-Year Surveillance in Shanghai, China , 2012, Journal of Clinical Microbiology.

[16]  C. Lowndes,et al.  Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales. , 2011, The Journal of antimicrobial chemotherapy.

[17]  Xiangsheng Chen,et al.  Molecular Typing of Treponema pallidum: A Systematic Review and Meta-Analysis , 2011, PLoS neglected tropical diseases.

[18]  M. Golden,et al.  Enhanced molecular typing of treponema pallidum: geographical distribution of strain types and association with neurosyphilis. , 2010, The Journal of infectious diseases.

[19]  I. Martin,et al.  Molecular Characterization of Syphilis in Patients in Canada: Azithromycin Resistance and Detection of Treponema pallidum DNA in Whole-Blood Samples versus Ulcerative Swabs , 2009, Journal of Clinical Microbiology.

[20]  L. Finelli,et al.  Molecular subtyping of Treponema pallidum in an Arizona County with increasing syphilis morbidity: use of specimens from ulcers and blood. , 2001, The Journal of infectious diseases.

[21]  W. Al-Soud,et al.  Purification and Characterization of PCR-Inhibitory Components in Blood Cells , 2001, Journal of Clinical Microbiology.

[22]  S. Morse,et al.  Molecular Subtyping of Treponema pallidum Subspecies pallidum , 1998, Sexually transmitted diseases.